218 related articles for article (PubMed ID: 24278309)
21. Acetate supplementation increases brain histone acetylation and inhibits histone deacetylase activity and expression.
Soliman ML; Rosenberger TA
Mol Cell Biochem; 2011 Jun; 352(1-2):173-80. PubMed ID: 21359531
[TBL] [Abstract][Full Text] [Related]
22. A safety trial of high dose glyceryl triacetate for Canavan disease.
Segel R; Anikster Y; Zevin S; Steinberg A; Gahl WA; Fisher D; Staretz-Chacham O; Zimran A; Altarescu G
Mol Genet Metab; 2011 Jul; 103(3):203-6. PubMed ID: 21474353
[TBL] [Abstract][Full Text] [Related]
23. Acetate Revisited: A Key Biomolecule at the Nexus of Metabolism, Epigenetics, and Oncogenesis - Part 2: Acetate and ACSS2 in Health and Disease.
Moffett JR; Puthillathu N; Vengilote R; Jaworski DM; Namboodiri AM
Front Physiol; 2020; 11():580171. PubMed ID: 33304273
[TBL] [Abstract][Full Text] [Related]
24. Brain-derived neurotrophic factor deficiency restricts proliferation of oligodendrocyte progenitors following cuprizone-induced demyelination.
Tsiperson V; Huang Y; Bagayogo I; Song Y; VonDran MW; DiCicco-Bloom E; Dreyfus CF
ASN Neuro; 2015; 7(1):. PubMed ID: 25586993
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21
Tseng TH; Chien MH; Lin WL; Wen YC; Chow JM; Chen CK; Kuo TC; Lee WJ
Environ Toxicol; 2017 Feb; 32(2):434-444. PubMed ID: 26872304
[TBL] [Abstract][Full Text] [Related]
26. Acetate, the key modulator of inflammatory responses in acute alcoholic hepatitis.
Kendrick SF; O'Boyle G; Mann J; Zeybel M; Palmer J; Jones DE; Day CP
Hepatology; 2010 Jun; 51(6):1988-97. PubMed ID: 20232292
[TBL] [Abstract][Full Text] [Related]
27. Sox2 is required to maintain cancer stem cells in a mouse model of high-grade oligodendroglioma.
Favaro R; Appolloni I; Pellegatta S; Sanga AB; Pagella P; Gambini E; Pisati F; Ottolenghi S; Foti M; Finocchiaro G; Malatesta P; Nicolis SK
Cancer Res; 2014 Mar; 74(6):1833-44. PubMed ID: 24599129
[TBL] [Abstract][Full Text] [Related]
28. Mechanism for the decrease in the FIP1L1-PDGFRalpha protein level in EoL-1 cells by histone deacetylase inhibitors.
Ishihara K; Kaneko M; Kitamura H; Takahashi A; Hong JJ; Seyama T; Iida K; Wada H; Hirasawa N; Ohuchi K
Int Arch Allergy Immunol; 2008; 146 Suppl 1():7-10. PubMed ID: 18504399
[TBL] [Abstract][Full Text] [Related]
29. Local histone acetylation by ACSS2 promotes gene transcription for lysosomal biogenesis and autophagy.
Li X; Qian X; Lu Z
Autophagy; 2017 Oct; 13(10):1790-1791. PubMed ID: 28820290
[TBL] [Abstract][Full Text] [Related]
30. Docosahexaenoic Acid Inhibits Proliferation of EoL-1 Leukemia Cells and Induces Cell Cycle Arrest and Cell Differentiation.
Moustaka K; Maleskou E; Lambrianidou A; Papadopoulos S; Lekka ME; Trangas T; Kitsiouli E
Nutrients; 2019 Mar; 11(3):. PubMed ID: 30866528
[TBL] [Abstract][Full Text] [Related]
31. N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.
Francis JS; Wojtas I; Markov V; Gray SJ; McCown TJ; Samulski RJ; Bilaniuk LT; Wang DJ; De Vivo DC; Janson CG; Leone P
Neurobiol Dis; 2016 Dec; 96():323-334. PubMed ID: 27717881
[TBL] [Abstract][Full Text] [Related]
32. ATP citrate lyase knockdown induces growth arrest and apoptosis through different cell- and environment-dependent mechanisms.
Zaidi N; Royaux I; Swinnen JV; Smans K
Mol Cancer Ther; 2012 Sep; 11(9):1925-35. PubMed ID: 22718913
[TBL] [Abstract][Full Text] [Related]
33. The novel histone deacetylase inhibitor BML-210 exerts growth inhibitory, proapoptotic and differentiation stimulating effects on the human leukemia cell lines.
Savickiene J; Borutinskaite VV; Treigyte G; Magnusson KE; Navakauskiene R
Eur J Pharmacol; 2006 Nov; 549(1-3):9-18. PubMed ID: 16978604
[TBL] [Abstract][Full Text] [Related]
34. PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.
Cenciarelli C; Marei HE; Felsani A; Casalbore P; Sica G; Puglisi MA; Cameron AJ; Olivi A; Mangiola A
Oncotarget; 2016 Aug; 7(33):53047-53063. PubMed ID: 27344175
[TBL] [Abstract][Full Text] [Related]
35. Targeting Histone Deacetylase Activity to Arrest Cell Growth and Promote Neural Differentiation in Ewing Sarcoma.
Souza BK; da Costa Lopez PL; Menegotto PR; Vieira IA; Kersting N; Abujamra AL; Brunetto AT; Brunetto AL; Gregianin L; de Farias CB; Thiele CJ; Roesler R
Mol Neurobiol; 2018 Sep; 55(9):7242-7258. PubMed ID: 29397557
[TBL] [Abstract][Full Text] [Related]
36. Superior inhibitory efficacy of butyrate over propionate and acetate against human colon cancer cell proliferation via cell cycle arrest and apoptosis: linking dietary fiber to cancer prevention.
Zeng H; Hamlin SK; Safratowich BD; Cheng WH; Johnson LK
Nutr Res; 2020 Nov; 83():63-72. PubMed ID: 33017771
[TBL] [Abstract][Full Text] [Related]
37. Clonal analysis for elucidating the lineage potential of embryonic NG2+ cells.
Ju PJ; Liu R; Yang HJ; Xia YY; Feng ZW
Cytotherapy; 2012 May; 14(5):608-20. PubMed ID: 22277011
[TBL] [Abstract][Full Text] [Related]
38. Lack of aspartoacylase activity disrupts survival and differentiation of neural progenitors and oligodendrocytes in a mouse model of Canavan disease.
Kumar S; Biancotti JC; Matalon R; de Vellis J
J Neurosci Res; 2009 Nov; 87(15):3415-27. PubMed ID: 19739253
[TBL] [Abstract][Full Text] [Related]
39. Differential effects of chemokines on oligodendrocyte precursor proliferation and myelin formation in vitro.
Kadi L; Selvaraju R; de Lys P; Proudfoot AE; Wells TN; Boschert U
J Neuroimmunol; 2006 May; 174(1-2):133-46. PubMed ID: 16574247
[TBL] [Abstract][Full Text] [Related]
40. Adeno-associated virus-mediated aspartoacylase gene transfer to the brain of knockout mouse for canavan disease.
Matalon R; Surendran S; Rady PL; Quast MJ; Campbell GA; Matalon KM; Tyring SK; Wei J; Peden CS; Ezell EL; Muzyczka N; Mandel RJ
Mol Ther; 2003 May; 7(5 Pt 1):580-7. PubMed ID: 12718900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
